Trials / Completed
CompletedNCT04164355
Study of Retinal and Choriocapillary Vascular Changes in Patients Undergoing Tadalafil 20mg
Evaluation of Retinal and Choriocapillary Vascular Changes Using Optical Coherence Tomography Angiography in Patients Undergoing Tadalafil 20mg on Alternative Days: a Single-centre Prospective-control
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- Federico II University · Academic / Other
- Sex
- Male
- Age
- 45 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the retinal and choriocapillary vascular features in patients under the effects of Tadalafil 20mg using optical coherence tomography angiography.
Detailed description
Tadalafil is a an inhibitor of the enzyme phosphodiesterase and it works by increasing blood flow to the penis thus promoting the erection. This drug represents an treatment for erectile dysfunction in patients after radical prostatectomy. The optical coherence tomography angiography represents a novel and non-invasive diagnostic technique that allows a detailed and quantitative analysis of retinal and choriocapillary vascular features. The study evaluates the changes in optical coherence tomography angiography parameters at baseline and after 1, 3, 6 months after the somministration of Tadalafil 20 mg orally.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tadalafil 20 MG | To study retinal and choriocapillary features in patients undergoing Tadalafil 20 mg orally, on alternate days, at baseline and 1, 3, 6 months after radical prostatectomy |
Timeline
- Start date
- 2020-07-04
- Primary completion
- 2021-04-25
- Completion
- 2021-04-30
- First posted
- 2019-11-15
- Last updated
- 2021-09-24
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04164355. Inclusion in this directory is not an endorsement.